Chemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsAdjuvants, ImmunologicCombined Modality TherapyBreast NeoplasmsCyclophosphamideTreatment OutcomeNeoplasm StagingDisease-Free SurvivalRadiotherapy, AdjuvantAntineoplastic AgentsCisplatinDoxorubicinSurvival AnalysisPrognosisFluorouracilNeoplasm Recurrence, LocalFreund's AdjuvantSurvival RateMethotrexateNeoadjuvant TherapyDrug Administration ScheduleAdjuvants, PharmaceuticLymphatic MetastasisLung NeoplasmsAntimetabolites, AntineoplasticFollow-Up StudiesTegafurPaclitaxelAnthracyclinesAdenocarcinomaCarboplatinTaxoidsEpirubicinLevamisoleEtoposideVinblastineTamoxifenColonic NeoplasmsKaplan-Meier EstimateTime FactorsMastectomyRandomized Controlled Trials as TopicColorectal NeoplasmsCarcinoma, Non-Small-Cell LungClinical Trials as TopicOrganoplatinum CompoundsNeoplasm MetastasisDeoxycytidineProspective StudiesAntineoplastic Agents, HormonalTumor Markers, BiologicalStomach NeoplasmsAntineoplastic Agents, AlkylatingLomustineReceptors, EstrogenIfosfamideDrug Resistance, NeoplasmBleomycinProportional Hazards ModelsMultivariate AnalysisSarcomaRetrospective StudiesTesticular NeoplasmsRadiotherapyOsteosarcomaReceptor, erbB-2Ovarian NeoplasmsNeoplasmsAntibiotics, AntineoplasticCystectomyRectal NeoplasmsGastrectomyInduction ChemotherapyBone NeoplasmsOxonic AcidLeucovorinMitomycinNeutropeniaRecurrenceThiotepaPremenopauseAntineoplastic Agents, PhytogenicUracilPneumonectomyClinical Trials, Phase III as TopicCarcinomaLymph Node ExcisionLymph NodesSalvage TherapyBrain NeoplasmsRadiotherapy DosageNeoplasms, Germ Cell and EmbryonalMedical OncologyVomitingAntineoplastic ProtocolsBridged CompoundsQuality of LifeDacarbazineInfusions, Intravenous